BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22297055)

  • 1. Safety of Ramadan fasting in young patients with type 1 diabetes: A systematic review and meta-analysis.
    Loh HH; Lim LL; Loh HS; Yee A
    J Diabetes Investig; 2019 Nov; 10(6):1490-1501. PubMed ID: 30938074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes.
    ; Russell SJ; Beck RW; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Calhoun P; Wadwa RP; Buckingham B; Zhou K; Daniels M; Raskin P; White PC; Lynch J; Pettus J; Hirsch IB; Goland R; Buse JB; Kruger D; Mauras N; Muir A; McGill JB; Cogen F; Weissberg-Benchell J; Sherwood JS; Castellanos LE; Hillard MA; Tuffaha M; Putman MS; Sands MY; Forlenza G; Slover R; Messer LH; Cobry E; Shah VN; Polsky S; Lal R; Ekhlaspour L; Hughes MS; Basina M; Hatipoglu B; Olansky L; Bhangoo A; Forghani N; Kashmiri H; Sutton F; Choudhary A; Penn J; Jafri R; Rayas M; Escaname E; Kerr C; Favela-Prezas R; Boeder S; Trikudanathan S; Williams KM; Leibel N; Kirkman MS; Bergamo K; Klein KR; Dostou JM; Machineni S; Young LA; Diner JC; Bhan A; Jones JK; Benson M; Bird K; Englert K; Permuy J; Cossen K; Felner E; Salam M; Silverstein JM; Adamson S; Cedeno A; Meighan S; Dauber A
    N Engl J Med; 2022 Sep; 387(13):1161-1172. PubMed ID: 36170500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial.
    Garg SK; Grunberger G; Weinstock R; Lawson ML; Hirsch IB; DiMeglio LA; Pop-Busui R; Philis-Tsimikas A; Kipnes M; Liljenquist DR; Brazg RL; Kudva YC; Buckingham BA; McGill JB; Carlson AL; Criego AB; Christiansen MP; Kaiserman KB; Griffin KJ; Forlenza GP; Bode BW; Slover RH; Keiter A; Ling C; Marinos B; Cordero TL; Shin J; Lee SW; Rhinehart AS; Vigersky RA;
    Diabetes Technol Ther; 2023 Jan; 25(1):1-12. PubMed ID: 36472543
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: An observational cohort study.
    Nakamura T; Fujikura J; Anazawa T; Ito R; Ogura M; Okajima H; Uemoto S; Inagaki N
    J Diabetes Investig; 2020 Mar; 11(2):363-372. PubMed ID: 31390159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Insulin Pump Therapy Versus Multiple Daily Injections for Glycemic Control and Rate of Diabetic Ketoacidosis Among Children With Type 1 Diabetes Mellitus.
    Alnaim N; Al Ghadeer HA; Al-Bunyan AA; Almulhem A; Alsaleh Y; AlHelal M; Almugaizel I; Alhashim Z; Alhamrani AM; Al Bosrour ZA
    Cureus; 2024 Feb; 16(2):e54123. PubMed ID: 38487160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Insulin Lispro Pharmacokinetics and Pharmacodynamics Over 10 Days of Continuous Insulin Infusion in People With Type 1 Diabetes.
    Garhyan P; Pratt E; Klein O; Famulla S; Zijlstra E; Lalonde A; Swinney M; Kazda C; Dassau E
    J Diabetes Sci Technol; 2023 Mar; 17(2):274-282. PubMed ID: 36575993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin Pump-Associated Adverse Events in a Brazilian Reference Center for the Treatment of Diabetes Mellitus: Proposal for a Taxonomy of Device Failures in Adults, Adolescents, and Children.
    Neves ALD; Martins LEG; Gabbay MAL; Cavicchioli G; Tenorio FS; Cunha TS
    J Diabetes Sci Technol; 2024 Jan; 18(1):74-81. PubMed ID: 35771027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance.
    Nakamura Y; Nagao M; Kobayashi S; Oba T; Shuto Y; Fukuda I; Oikawa S; Sugihara H
    J Diabetes Investig; 2020 Sep; 11(5):1370-1373. PubMed ID: 32267995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemia Risk Index Assessment in a Pediatric and Adult Patient Cohort With Type 1 Diabetes Mellitus.
    Díaz-Soto G; Pérez-López P; Férnandez-Velasco P; Nieto de la Marca MO; Delgado E; Del Amo S; de Luis D; Bahillo-Curieses P
    J Diabetes Sci Technol; 2023 Feb; ():19322968231154561. PubMed ID: 36794818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of insulin glulisine to improve glycemic control in children with diabetes mellitus.
    Lih A; Hibbert E; Wong T; Girgis CM; Garg N; Carter JN
    Diabetes Metab Syndr Obes; 2010 Nov; 3():403-12. PubMed ID: 21437110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: Do the benefits outweigh the risks?
    Toth GH
    Paediatr Child Health; 2005 Jan; 10(1):28-30. PubMed ID: 19657442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exogenous insulin antibody syndrome in a patient with diabetes secondary to total pancreatectomy.
    Obata Y; Takayama K; Nishikubo H; Tobimatsu A; Matsuda I; Uehara Y; Maruo Y; Sho H; Kosugi M; Yasuda T
    Diabetol Int; 2023 Apr; 14(2):211-216. PubMed ID: 37090132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous Insulin Antibody Syndrome (EIAS) Presenting in an Elderly, Long-Term Patient with Type 1 Diabetes Mellitus that Resolved with Low-Cost Outpatient Therapy with Mycophenolate Mofetil and Regular Insulin by Pump.
    Jerkins T; Stockham K; Bell DSH
    Diabetes Ther; 2024 Jun; 15(6):1473-1481. PubMed ID: 38653902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies.
    Vincent M; Nobécourt E
    Diabetes Metab; 2013 Sep; 39(4):299-305. PubMed ID: 23642642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding of type 1 diabetes mellitus: what we know and where we go.
    Cheon CK
    Korean J Pediatr; 2018 Oct; 61(10):307-314. PubMed ID: 30304895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics.
    Pozzilli P; Battelino T; Danne T; Hovorka R; Jarosz-Chobot P; Renard E
    Diabetes Metab Res Rev; 2016 Jan; 32(1):21-39. PubMed ID: 25865292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.
    Kaiserman K; Rodriguez H; Stephenson A; Wolka L; Fahrbach JL
    Endocr Pract; 2012; 18(3):418-24. PubMed ID: 22297055
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.